![](/img/cover-not-exists.png)
Low expression levels of ATM may substitute forCHEK2/TP53mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
Stian Knappskog, Ranjan Chrisanthar, Erik Løkkevik, Gun Anker, Bjørn Østenstad, Steinar Lundgren, Terje Risberg, Ingvil Mjaaland, Beryl Leirvaag, Hrvoje Miletic, Per E LønningVolume:
14
Language:
english
DOI:
10.1186/bcr3147
Date:
April, 2012
File:
PDF, 453 KB
english, 2012